0
0
0
0
India produces 60 percent of the vaccine produced worldwide, but after America, the highest number of cases of Covid-19 have also come in this country.
India not only has to vaccinate its people but also has to fulfill its commitment to other countries of the world. Can India meet this demand?
Two vaccines have been approved in India right now – Kovishield which is making Oxford and AstraZeneca and the other one is Kovaxin.
Some other vaccines that are currently undergoing trials are also being produced in India.
India’s pharmaceutical companies have stepped up production in recent months. According to Serum Institute of India, which is the largest producer, according to them, they can produce 6 crore to 7 crore vaccines every month.
According to Bharat Biotech, they can produce 200 million vaccines in a year, although they currently have only 20 million doses of cocaine.
Other companies whose vaccine is undergoing trials are also talking to Indian authorities and other countries, so that the vaccine can be supplied when it is ready. Although there is not much information related to them.
The Government of India has said that it will give vaccines to 300 million people by the end of July. The vaccination program will start from January 16 and vaccine will be given to the frontline and healthcare workers first. There is a plan to vacate 60 crore people in seven months, that is, about 8.5 crore doses every month.
The Serum Institute of India is part of the Kovacs Scheme supported by the World Health Organization. Its purpose is to make vaccines available to middle income countries.
In September last year, the Serum Institute had promised to provide 200 million doses under this scheme – it could be the Oxford-AstraZeneca vaccine or the US Novax dose.
Chief Executive of Serum Institute of India Adar Poonawala told that this agreement could be increased to 90 crore doses.
If this happens, the commitment of Serum Institute of India will be 1 billion doses.
The company said that it is their effort to increase production to 10 million doses per month.
In addition to the Kovacs scheme, the Serum Institute of India has entered into bilateral commercial deals with several countries to supply the Oxford-AstraZeneca vaccine.
Poonawala said earlier this month that the vaccines were approved on the condition that they would not be exported, but according to him, this was an illusion.
After Bangladesh expressed concern, the Indian government later clarified that exports would be allowed, a deal with Bangladesh to get 3 crore initial doses.
A Foreign Ministry official told that India, “as the world’s largest vaccine manufacturer, is fully conscious of its commitments to neighbors and the rest of the world.”
Apart from this, the company has also made deals with Saudi Arabia, Myanmar and Morocco. Although how much vaccine, how long they need, it is not clear yet.
There are reports that Nepal, Brazil and Sri Lanka may also show interest in vaccines made in India. But Poonawala has said that his priority will be to meet the domestic demand.
“Once we meet the initial requirements, then we will soon start exporting it to other countries.”
A spokesman for the global vaccine alliance Gavi, who is helping to run the Kovacs scheme, told that they are in regular contact with both Indian authorities and the Serum Institute of India.
He said he is “confident” that there will be no delay in commitment to Kovacs.
Virologist Dr. Shaheed Jameel explains that the Kovacs plan is an international obligation, which would also not be good if Indian companies prohibit bilateral deals already agreed with other countries.
He said that given the current availability, “I am not worried that there will be a shortage of vaccines in India”
According to him, “the hindrance will be how fast we actually vaccinate people”
Another potential bottleneck is the availability of glass vials used for vaccines. There are concerns around the world that there may be a shortage of vials.
However, according to the Serum Institute of India, he has not yet faced any such shortage.
Ajaz Yunus Patel is a cricketer born in Mumbai, India, on October 21, 1988. He…
Ajaz Patel, the skilled left-arm spinner from New Zealand, gained international attention in 2021 when…
Are you dealing with an unusual headache? It could be a cervical or cervicogenic headache.…
In a shocking development, YouTuber Praneeth Hanumanthu has become embroiled in controversy following his detention by the Telangana Cyber Security Bureau. Initially arrested for making offensive remarks during a podcast, Hanumanthu's predicament has escalated, resulting in further allegations under the Narcotic Drugs and Psychotropic Substances (NDPS) Act after he tested positive for cannabis consumption. The Context of the Detention The origins of Hanumanthu's difficulties can be linked to a podcast he hosted, which included a conversation that many considered highly unseemly. During this episode, he made inappropriate comments regarding the dynamics between a father and daughter, igniting outrage among viewers and critics alike. This incident quickly garnered the attention of both the public and law enforcement, prompting an investigation by the Telangana Cyber Security Bureau. The primary allegation centered around his remarks, which were deemed to have crossed the boundaries of acceptable discourse. This scenario raises broader inquiries about accountability and the duties of content creators, particularly in an era where online platforms can amplify messages to a large audience. As a public figure, Hanumanthu's statements carry substantial weight, and the backlash he has encountered signifies society's increasing intolerance towards harmful rhetoric. Charges Related to Substances Things took a turn for the worse for Hanumanthu when, following his arrest, authorities opted to perform a drug test. The results confirmed the presence of cannabis in his system, leading to additional allegations under the NDPS Act. This legislation is a strict law in India aimed at combating substance abuse and trafficking. By testing positive for drug use, Hanumanthu not only worsened his legal troubles but also further tarnished his reputation. The addition of drug-related charges initiates an important discourse about the effects of substance use among influencers and celebrities. Many young individuals look up to figures like Hanumanthu, and such disclosures can have significant consequences on their perceptions and behaviors. The fallout from his actions extends beyond legal issues; it also encompasses the ethical obligations that accompany public visibility. Reactions from the Public and Consequences The public’s reaction to Hanumanthu's arrest has been varied. Many viewers voiced their outrage over both his initial remarks and his later substance use. Social media has been inundated with discussions, memes, and criticisms, illustrating the swift spread of information and opinions in today’s digital environment. Critics contend that individuals like Hanumanthu should be held accountable for their influence, particularly when it concerns endorsing a healthy lifestyle and responsible behavior. On the other hand, some supporters have rallied behind him, advocating for the necessity of empathy and understanding. They highlight the pressures that accompany being a public figure, especially in a hyper-connected world where every action is scrutinized. This divide in public sentiment mirrors a broader societal conversation about celebrity culture, accountability, and the intricacies of mental health and substance use. The Wider Picture of Substance Abuse Hanumanthu's situation is also part of a larger discourse regarding drug abuse in India, especially among the youth. As discussions about mental health and substance use become more widespread, incidents like this underscore the pressing need for awareness and education about addiction and its root causes. The stigma surrounding drug use often hampers open dialogue about the topic, leaving many to endure in silence. Moreover, the legal implications of the NDPS Act spark questions about how society addresses drug-related offenses. While the act aims to deter substance abuse, critics argue that such laws can disproportionately impact certain demographics and do not tackle the underlying causes of addiction. Conversations around harm reduction, rehabilitation, and public health strategies are increasingly relevant within the framework of these laws. Prospects Ahead for Hanumanthu As Hanumanthu navigates the forthcoming legal hurdles, his future remains unpredictable. He faces possible legal repercussions for both his unsatisfactory comments and his substance use, which could greatly affect his career and personal life. The scenario serves as a cautionary example for content creators about the consequences of their expressions and actions, highlighting the need for thoughtful engagement with their audience.…
Nimrat Kaur is an Indian actress celebrated for her contributions to Hindi cinema and American…
Grey divorce refers to the increasing trend of couples aged 50 and older choosing to…